Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Abbott buys rest of Evalve for $320mm plus earn-outs

Executive Summary

Abbott is buying the remaining 90% of Evalve (minimally invasive devices for cardiac mitral valve repair) that it does not already own for $320mm up front plus potential earn-outs of $90mm based on regulatory approvals.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Includes Earnout

Related Companies

Advertisement
UsernamePublicRestriction

Register